Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Centers for Disease Control and Prevention |
---|---|
Information provided by: | Centers for Disease Control and Prevention |
ClinicalTrials.gov Identifier: | NCT00252083 |
This study will look at the following questions:
Hypothesis: There will be a significant increase in HIV prevention knowledge, intentions, and self efficacy concerning condom use. There will be a decrease in risk attitudes, norms, number of sexual partners, and incidence of unprotected anal intercourse among seropositive Hispanic MSM after the implementation of ADAPT-POL.
Hypothesis: Intervention exposure and dosage are positively correlated with improved HIV prevention knowledge, attitudes, intentions, and behaviors concerning unprotected anal intercourse.
Condition | Intervention |
---|---|
HIV Infections |
Behavioral: Popular Opinion Leader |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Efficacy Study |
Official Title: | Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques With Popular Opinion Leader (ADAPT-POL) |
Estimated Enrollment: | 200 |
Study Start Date: | July 2004 |
Estimated Study Completion Date: | June 2007 |
The proposed project, Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), has two main goals: first, to assist the Centers for Disease Control and Prevention (CDC) to better understand the processes needed for adapting evidence-based behavioral interventions to fit new conditions or target populations; second, to utilize the CDC’s draft adaptation guidance to adapt Jeff Kelly’s Popular Opinion Leader (POL) for use with adult, seropositive Hispanic men who have sex with other men (MSM). The target population will directly participate in all phases of the intervention adaptation process.
ADAPT, known as ADAPT-POL in El Paso, will include formative research and outcome monitoring. Throughout both periods, the ADAPT-POL staff will conduct process monitoring and evaluation to assess the delivery of the intervention, and to help the CDC understand how the draft adaptation guidance procedures work in a real world setting. Representatives of the target population will participate in focus groups, key informant interviews, and community advisor meetings during the formative phase; and potentially serve as popular opinion leaders (POLs) during the implementation phase.
The knowledge obtained during the ADAPT-POL intervention will be diffused to other interventions and programs at the Planned Parenthood Center of El Paso (PPCEP). This will allow PPCEP management and staff to make informed decisions about the adoption of interventions and what steps might be necessary to adapt existing and future PPCEP interventions that target Hispanic populations. At the conclusion of ADAPT activities, the CDC-developed draft adaptation guidance will be revised based on lessons learned.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Vel S. McKleroy, MPH, BSW | 404-639-2982 | vmckleroy@cdc.gov |
Contact: Jennifer Galbraith, PhD | 404-639-8649 | jgalbraith@cdc.gov |
United States, Texas | |
Planned Parenthood Center of El Paso | Recruiting |
El Paso, Texas, United States, 79902 | |
Contact: Irma Carrillo, MPH 915-544-8195 ext 250 irma.carrillo@ppcep.org | |
Contact: Marci Brooks, MA (915) 544-8195 marci.brooks@ppcep.org | |
Principal Investigator: Ferreira-Pinto Joao, PhD |
Principal Investigator: | Vel S McKleroy, MPH, BSW | Centers for Disease Control and Prevention |
Study ID Numbers: | CDC-NCHSTP-U65/CCU623833, U65/CCU623833-01-1 |
Study First Received: | November 10, 2005 |
Last Updated: | June 4, 2007 |
ClinicalTrials.gov Identifier: | NCT00252083 |
Health Authority: | United States: Federal Government |
Seropositive MSM Hispanic Popular Opinion Leader HIV |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Retroviridae Infections Mineral Oil Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |